Qi Tian
Research Subjects
Research Interests
Qi Tian has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- An-Yue Wu
Department of Obstetrics and Gynaecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, China
1 shared publication - Dong Li
Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, 200127, China; Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, China
1 shared publication - Fang Ji
Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, 200127, China; Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, China
1 shared publication He-Fen Sun
Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200030, PR China
1 shared publicationJie Ding
Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, PR China
1 shared publication- Li-Ying Gu
Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, 200127, China; Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, 200127, China
1 shared publication
Latest Publications
- 1 September 2019
- Published by Elsevier in Experimental Cell Research
- Vol. 382 (2) , 111468
Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis
- 1 September 2019
- Published by Elsevier in Experimental Cell Research
- Vol. 382 (2) , 111468
Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis
- 3 April 2019
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (17) , 2019-2028
MiRNA-365B Promotes Hepatocellular Carcinoma Cell Migration and Invasion By Downregulating SGTB
Aim: miR-365b, a miRNA at chromosomal breakpoint, was often amplified and upregulated in human hepatocellular carcinoma (HCC). However, the role of miR-365b dysregulation remains unclear. Materials & methods: miR-365b function assays and its target gene analyses were performed. Results: We revealed that miR-365b promoted HCC cell motility and spreading. Furthermore, SGTB was found to be a downstream target of miR-365b, and knockdown of the SGTB gene could mimic the effect of miR-365b in hastening HCC cell migration and invasion. Conclusion: These results imply that miR-365b plays a tumor-promoting role in HCC by suppressing SGTB expression, offering novel potential targets for the treatment of HCC.
- 3 April 2019
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (17) , 2019-2028
MiRNA-365B Promotes Hepatocellular Carcinoma Cell Migration and Invasion By Downregulating SGTB
Aim: miR-365b, a miRNA at chromosomal breakpoint, was often amplified and upregulated in human hepatocellular carcinoma (HCC). However, the role of miR-365b dysregulation remains unclear. Materials & methods: miR-365b function assays and its target gene analyses were performed. Results: We revealed that miR-365b promoted HCC cell motility and spreading. Furthermore, SGTB was found to be a downstream target of miR-365b, and knockdown of the SGTB gene could mimic the effect of miR-365b in hastening HCC cell migration and invasion. Conclusion: These results imply that miR-365b plays a tumor-promoting role in HCC by suppressing SGTB expression, offering novel potential targets for the treatment of HCC.